CCCCC4 Therapeutics, Inc.

Nasdaq c4therapeutics.com


$ 6.27 $ -0.10 (-1.57 %)    

Monday, 29-Apr-2024 10:00:52 EDT
QQQ $ 431.99 $ -1.16 (-0.27 %)
DIA $ 383.20 $ -0.10 (-0.03 %)
SPY $ 509.88 $ -0.52 (-0.1 %)
TLT $ 88.53 $ -0.13 (-0.15 %)
GLD $ 216.08 $ 0.03 (0.01 %)
$ 6.17
$ 6.37
$ 6.24 x 100
$ 6.26 x 100
$ 6.22 - $ 6.37
$ 1.06 - $ 11.88
1,047,766
na
306.28M
$ 2.35
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-22-2024 12-31-2023 10-K
2 11-01-2023 09-30-2023 10-Q
3 08-08-2023 06-30-2023 10-Q
4 05-04-2023 03-31-2023 10-Q
5 02-23-2023 12-31-2022 10-K
6 11-03-2022 09-30-2022 10-Q
7 08-04-2022 06-30-2022 10-Q
8 05-05-2022 03-31-2022 10-Q
9 02-24-2022 12-31-2021 10-K
10 11-10-2021 09-30-2021 10-Q
11 08-11-2021 06-30-2021 10-Q
12 05-13-2021 03-31-2021 10-Q
13 03-11-2021 12-31-2020 10-K
14 11-12-2020 09-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 c4-therapeutics-presents-new-preclinical-data-for-cft1946-highlighting-superior-activity-as-a-single-agent-to-clinically-approved-braf-inhibitor-standard-of-care-combinations-at-the-american-association-for-cancer-research-annual-meeting-2024

C4 Therapeutics, Inc. (C4T) (NASDAQ:CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein d...

 c4-therapeutics-to-present-new-preclinical-data-on-highly-selective-orally-bioavailable-bidac-degraders-at-the-american-association-for-cancer-research-annual-meeting-2024

C4 Therapeutics, Inc. (C4T) (NASDAQ:CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein d...

 morgan-stanley-maintains-equal-weight-on-c4-therapeutics-raises-price-target-to-8

Morgan Stanley analyst Terence Flynn maintains C4 Therapeutics (NASDAQ:CCCC) with a Equal-Weight and raises the price target...

 c4-therapeutics-fy-eps-267-down-from-262-yoy-sales-2076m-down-from-3110m-yoy

C4 Therapeutics (NASDAQ:CCCC) reported quarterly losses of $(2.67) per share. This is a 1.91 percent decrease over losses of $(...

 capital-one-financial-to-acquire-discover-joins-ssr-mining-and-other-big-stocks-moving-lower-in-tuesdays-pre-market-session

U.S. stock futures were lower this morning, with the Dow futures trading lower by around 50 points on Tuesday.

 jp-morgan-upgrades-c4-therapeutics-to-neutral-announces-6-price-target

JP Morgan analyst Eric Joseph upgrades C4 Therapeutics (NASDAQ:CCCC) from Underweight to Neutral and announces $6 price target.

 c4-therapeutics-announces-2024-priorities-unaudited-cash-cash-equivalents-and-marketable-securities-totaling-330m-as-of-january-5-2024-to-advance-portfolio-of-targeted-protein-degradation-medicines-announces-workforce-reduction-of-30

Multiple 2024 Clinical Updates Expected, Including Data from the Ongoing CFT7455 and CFT1946 Phase 1 Dose Escalation Trials Pri...

 ra-capital-management-reports-99-passive-stake-in-c4-therapeutics

-SEC Filing

 c4-therapeutics-13g-filing-shows-commodore-capital-lp-reports-77-passive-stake-in-the-co-as-of-dec-14

- SEC Filing

 whats-going-on-with-c4-therapeutics-stock

C4 Therapeutics, Inc. (NASDAQ: CCCC) shares are trading higher Friday, and the stock has gained more than 350% over the past fi...

 dow-jumps-over-200-points-federal-reserve-holds-interest-rates-steady

U.S. stocks traded higher toward the end of trading, after the Federal Reserve announced its policy decision on Wednesday. The...

 why-despegarcom-shares-are-trading-higher-by-over-16-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of Despegar.com, Corp. (NYSE: DESP) rose sharply during Wednesday’s session after the company raised its FY23 financial ...

 crude-oil-gains-15-blackboxstocks-shares-plummet

U.S. stocks traded higher midway through trading, following the release of PPI data on Wednesday. The Dow traded up 0.06% to 3...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION